Michael D. Loberg, Director at IGM Biosciences, Inc. (IGMS), bought 9,539 shares at $18.57 ($93K) on 2019-09-18, disclosed to the SEC on 2019-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.57 | 5,000 | $93K | 100.0% |
| 2 | $0.00 | 4,539 | $0 | 0.0% |
| Total | $9.73 avg | 9,539 | $93K | 100% |
| Filing → |
| IGMS | BUY | 2022-04-04 | $500K | — | Filing → |
| ARQL | BUY | 2015-12-18 | $8K | — | Filing → |
| ARQL | BUY | 2015-12-17 | $3K | — | Filing → |